SICHUAN GOLDSTONE ASIA PHARMACEUTICAL INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.59 CNY | 0.00% |
|
+6.44% | -22.33% |
| Sales 2022 | 1.24B 171M 13.73B | Sales 2023 | 1.21B 167M 13.37B | Capitalization | 4.44B 613M 49.11B |
|---|---|---|---|---|---|
| Net income 2022 | 219M 30.22M 2.42B | Net income 2023 | 126M 17.39M 1.39B | EV / Sales 2022 | 4 x |
| Net cash position 2022 | 494M 68.15M 5.46B | Net cash position 2023 | 473M 65.34M 5.23B | EV / Sales 2023 | 3.28 x |
| P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
35.7
x | Employees | 1,878 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 38.99% |
More Fundamentals
* Assessed data
More news
| 1 week | +6.44% | ||
| Current month | -2.83% | ||
| 1 month | -1.94% | ||
| 3 months | -12.44% | ||
| 6 months | -27.51% | ||
| Current year | -22.33% |
1 week
8.21
8.67
1 month
7.799.33
Current year
6.8911.29
1 year
6.8918.18
3 years
6.8923.16
5 years
6.7023.16
10 years
3.8845.55
| Managers | Title | Age | Since |
|---|---|---|---|
Bao Kang Wei
CEO | Chief Executive Officer | 56 | 08/12/19 |
Qing Guo Wang
DFI | Director of Finance/CFO | 49 | 24/08/22 |
Zhi Yong Zheng
BRD | Director/Board Member | 56 | 12/10/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Xi Kuai
BRD | Director/Board Member | 66 | 30/06/04 |
Qiang Lin
BRD | Director/Board Member | 60 | 30/06/04 |
Run Xiu Li
BRD | Director/Board Member | 55 | 30/06/04 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 8.59 | 0.00% | 4,838,500 |
| 25/04/24 | 8.59 | +2.26% | 3,275,300 |
| 24/04/24 | 8.4 | +0.72% | 2,189,700 |
| 23/04/24 | 8.34 | +2.08% | 3,036,100 |
| 22/04/24 | 8.17 | +1.24% | 2,343,100 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Sichuan Goldstone Asia Pharmaceutical Inc., formerly Sichuan Goldstone Orient New Material Equipment Inc, is a China-based company principally engaged in the production and sales of pharmaceutical products, as well as drug agency business. Its main products include health products, cracks and small cracks. The Company is also engaged in the machinery manufacturing business, as well as property leasing and management business. Its machinery products mainly include steel reinforced plastic pipe production line, bead winding steel reinforced pipe production line, production line equipment parts and other equipment. The Company mainly operates its businesses in domestic market.
Sector
Pharmaceuticals
Calendar
24/05/2024
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.33% | 476M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- 300434 Stock
